share_log

CBD Life Sciences Inc. Provides Shareholder Letter Update

CBD Life Sciences Inc. Provides Shareholder Letter Update

CBD生命科學公司提供股東信函更新
Accesswire ·  06/24 20:00

SCOTTSDALE, AZ / ACCESSWIRE / June 24, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, The CBD Vault Inc. (Formerly LBC Bioscience Inc.) is delighted to announce the transformation of LBC Bioscience Inc. into The CBD Vault Inc., reflecting our commitment to innovation and expansion within the thriving CBD market. Our rebranding marks a pivotal moment as we continue to grow and diversify our product offerings.

CBD Life Sciences Inc. (場外交易股票代碼:CBDL) 其全資子公司 The CBD Vault Inc. (前名 LBC Bioscience Inc.) 欣然宣佈 LBC Bioscience Inc. 改名爲 The CBD Vault Inc.,這反映了我們在欣欣向榮的CBD市場上的創新和擴張承諾。我們的重新品牌標誌着一個關鍵時刻,因爲我們繼續增長和多樣化我們的產品系列。

The CBD Vault Inc. now offers a diverse portfolio of over 60 premium products, including our top-selling pain creams and roll-ons tailored for athletes, as well as Delta-8 & Delta-10 top shelf gummies and cartridges, and a selection of Kava and Kratom beverages.

The CBD Vault Inc.目前可以提供60多種高級產品,其中包括我們暢銷的針對運動員量身定製的止痛霜和滾輪,以及Delta-8 & Delta-10頂級軟糖和煙彈,以及一系列卡瓦和克拉廷飲料。

In line with the company's growth strategy, The CBD Vault is enhancing its marketing capabilities by recruiting CBD marketing and advertising specialists. This initiative aims to drive greater awareness and revenue for the expanding product line. Additionally, the company is actively exploring opportunities to acquire a marijuana dispensary in the near future along with additional retail locations, further diversifying the market footprint.

配合本公司的增長策略,The CBD Vault正在招募CBD營銷和廣告專家,提升其營銷能力。此舉旨在推動擴大產品線的收入及提高客戶認知度。此外,本公司將積極探索在不久的將來收購大麻零售店和其他零售店的機會,進一步多樣化市場足跡。

The CBD market continues to demonstrate robust growth, driven by increasing public adoption and promising health and wellness trends associated with cannabidiol. The company is committed to capitalizing on these opportunities to deliver value to the shareholders.

CBD市場繼續表現出強勁增長,受到人們對大麻二酚有前景的健康和保健趨勢的推動。公司致力於利用這些機會爲股東提供價值。

Lisa Nelson, President/CEO of CBD Life Sciences Inc., expressed her appreciation: "I am proud of our team's dedication and the significant strides we have made. We owe our success to our loyal consumers and shareholders, and we thank you for your unwavering support." Lisa continued, "By strengthening our marketing efforts and exploring strategic acquisitions, we are positioning The CBD Vault Inc. for continued growth and success!"

CBD Life Sciences Inc. 的總裁兼首席執行官 Lisa Nelson 表示感激:"我爲我們團隊的奉獻和我們所取得的重大進展感到自豪。我們的成功歸功於我們忠誠的消費者和股東,感謝他們一直以來的支持。" Lisa 繼續說道:"通過加強我們的營銷力度和探索戰略性收購,我們將 The CBD Vault Inc. 定位爲持續增長和成功!"

As always, CBD Life Sciences Inc. remains committed to keeping you informed about new product releases, industry events, and all developments related to The CBD Vault Inc. Explore our comprehensive range of cannabidiol-based organic products on our website at

與往常一樣,CBD Life Sciences Inc. 一直致力於向您提供新產品發佈、行業活動以及與 The CBD Vault Inc. 相關的所有發展情況。請訪問我們的網站,了解我們全面的基於大麻二酚的有機產品。

Thank you for your continued trust and investment in CBD Life Sciences Inc.

感謝您繼續信任並投資 CBD Life Sciences Inc。

About The CBD Vault Inc.

關於The CBD Vault Inc。

The CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets. The CBD Vault's products can be viewed and purchased on the Company's website at

The CBD Vault Inc.是CBD Life Sciences Inc.的全資子公司。The CBD Vault已開發並零售/批發了一系列基於大麻二酚的有機產品,包括CBD滴劑、止痛霜、焦慮和睡眠補充劑、食品、咖啡、護膚系列、寵物系列、片劑。The CBD Vault的產品可以在公司的網站上查看和購買。

Follow our social media for the latest updates!

關注我們的社交媒體以獲取最新資訊!

X:

博客

Instagram:

Instagram:

IR Contact: cbdvaultaz@gmail.com

IR聯繫:cbdvaultaz@gmail.com

Forward-Looking Statements

前瞻性聲明

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

除了此文中包含的歷史信息外,本新聞稿所討論的事項均爲前瞻性聲明。實際結果可能與前瞻性聲明中描述的結果存在重大差異,並且可能會受到風險和不確定性的影響。請參閱 CBD Life Sciences, Inc. 的 OTC Markets 提交的文件,其中可能指出可能導致實際結果或事件與前瞻性聲明中描述的結果存在重大差異的具體因素。

Safe Harbor Statement

Safe Harbor聲明

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking.

此新聞稿包含前瞻性聲明,基於某些假設,反映了管理層的當前預期。這些前瞻性聲明受到多種風險和不確定性的影響,可能會導致實際結果或事件與當前預期存在重大差異。其中一些因素包括:全球經濟總體條件;行業和市場總體條件、行業增長率;是否能夠從我們的戰略和商業計劃中獲得預期的好處的不確定性;日益激烈的競爭;資本的可用性和成本;識別和開發並實現商業成功的級別;爲保持和提高服務質量而必要的支出水平;經濟狀況的變化;法律和法規的變化,包括編碼和標準、知識產權權利和稅收事項;或其他未預料到的事項;我們能夠確保並維護戰略關係和分銷協議的能力。公司不承擔任何更新或修訂任何前瞻性聲明的意圖或義務。

SOURCE: CBD Life Sciences Inc.

來源:CBD Life Sciences Inc.


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論